However, an earlier study performed in pancreatic cancer showed the limited clinical efficacy of CB-839 monotherapy [70] which highlights again that various GLS-1 inhibitors may cause significantly different effects on chromaffin cells’ proliferation. The gene discussed is GLS; the disease is pancreatic neoplasm.